Registering a CAGR of 9.4% over the forecast period, the market value of Ultrasonic Tissue Ablation System is expected to reach US$ 8200 million in the year 2027.
The growing elderly population has also increased the prevalence of target conditions, increasing the demand for effective treatment. However, device reuse and reprocessing in developed countries, as well as an unfavorable regulatory environment, are key factors limiting the market's growth. Product recalls and therapeutic challenges related to the efficacy of ablation products are significant challenges confronting industry participants in the global ablation technology market.
Minimally invasive procedures have seen a significant increase in demand in recent years due to the benefits they provide over traditional treatment procedures—fewer operative complications, shorter hospitalization, less pain, smaller & more cosmetic incisions, lower risk of infection, reduced post-operative care, and faster recovery. Advanced technologies are used in minimally invasive procedures to diagnose and treat a variety of diseases, including cancer. These techniques are used to remove cancer tumors and lymph nodes without leaving scars. Minimally invasive techniques also aid surgeons in tissue collection for biopsy and accurate staging studies. This enables surgeons to devise precise cancer treatment plans.
The report aspects discussed the profile of the top manufacturers of the global Ultrasonic Tissue Ablation System market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Ultrasonic Tissue Ablation System Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The global Ultrasonic Tissue Ablation System includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Abbott, AngioDynamics Inc., AtriCure Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC and others.
Industry News and Updates:
In June 2021, Boston Scientific announced the acquisition of FARAPULSE's remaining shares. Boston Scientific's electrophysiology segment was strengthened by the acquisition, which added pulsed-field ablation technology to its portfolio.
In January 2019, Medtronic has agreed to buy EPIX Therapeutics, Inc. (EPIX), a private company that develops and manufactures a catheter-based, temperature-controlled cardiac ablation system to treat patients with cardiac arrhythmias (irregular heartbeats), including AF.
By Type, it is segmented into
By Application, it is segmented into
Over the forecast period, North America will dominate the market.
Emerging markets, such as India, China, Mexico, and Brazil, offer significant growth opportunities in the ablation technology market, owing to factors such as initiatives undertaken by stakeholders across these countries, low regulatory barriers for trade, continuous improvements in healthcare infrastructure, a growing patient population, relatively low procedural costs for disease treatment (compared to developed countries), less stringent regulatory policies, and lax regulatory policies. Furthermore, these regions have seen an increase in the incidence and prevalence of lifestyle diseases such as cardiovascular disease and cancer.
The Ultrasonic Tissue Ablation System Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Ultrasonic Tissue Ablation System Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers Ultrasonic Tissue Ablation System Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Ultrasonic Tissue Ablation System Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Ultrasonic Tissue Ablation System Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Abbott, AngioDynamics Inc., AtriCure Inc |
Forecast Period 2022 to 2027 CAGR | CAGR of 9.4% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 95 |
Customization Available | Yes, the report can be customized as per your needs |
Frequently Asked Questions
What is the study period of this market?
The Ultrasonic Tissue Ablation System Market is studied from 2017 - 2027.
What is the growth rate of the Ultrasonic Tissue Ablation System Market?
The Ultrasonic Tissue Ablation System Market is growing at a CAGR of 9.4% over the next 5 years.
Who are the key players in Ultrasonic Tissue Ablation System Market?
Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC
What regions does this Ultrasonic Tissue Ablation System Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Ultrasonic Tissue Ablation System Market?
HIFU, MRgFUS
What are the major end-use applications of Ultrasonic Tissue Ablation System Market?
Uterine Fibroids, Other Cancers
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.